Impact of Sitagliptin on Neprilysin and Glycemic Control in Newly Diagnosed Type 2 Diabetes Patients
Medical Science Monitor · 2025
DOI: 10.12659/msm.949107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Cuma Bulent Gül und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey. Hauptthemen laut MEDLINE: Sitagliptin Phosphate, Diabetes Mellitus, Type 2, Neprilysin. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey.
- Department of Internal Medicine, Edirne Sultan Murat I State Hospital, Edirne, Turkey.
ORCID-Profile: Ensar Aydemir
Zitieren
APA
Gül, C. B., Oruc, A., Cander, S., Aydemir, E., & Oz Gül, O. (2025). Impact of Sitagliptin on Neprilysin and Glycemic Control in Newly Diagnosed Type 2 Diabetes Patients. Medical Science Monitor. https://doi.org/10.12659/msm.949107
Vancouver
Gül CB, Oruc A, Cander S, Aydemir E, Oz Gül O. Impact of Sitagliptin on Neprilysin and Glycemic Control in Newly Diagnosed Type 2 Diabetes Patients. Medical Science Monitor. 2025. doi:10.12659/msm.949107
BibTeX
@article{Gl2025,
author = {Gül, Cuma Bulent and Oruc, Aysegul and Cander, Soner and Aydemir, Ensar and Oz Gül, Ozen},
title = {Impact of Sitagliptin on Neprilysin and Glycemic Control in Newly Diagnosed Type 2 Diabetes Patients},
journal = {Medical Science Monitor},
year = {2025},
doi = {10.12659/msm.949107}
}
EUVIMED